Nimonata, Marvin .
HRN: 27-87-96 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/03/2025
10/16/2025
IV
4.5g
OD
CAP HR
Checking Initial Appropriateness
10/04/2025
LEVOFLOXACIN 500MG (TAB)
10/04/2025
10/10/2025
NGT
500mg
OD
Sepsis
Waiting Final Action
10/10/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/10/2025
10/16/2025
IV
4.5g IV
Q6
CAP HR
Checking Final Appropriateness